Zobrazeno 1 - 10 of 256 657 pro vyhledávání: '"heterocyclic"'
1
Akademický článek
Immuno-PET Imaging of EGFR with 64 Cu-NOTA Panitumumab in Subcutaneous and Metastatic Nonsmall Cell Lung Cancer Xenografts.
Autor: Sarrami N; Faculty of Pharmacy and Pharmaceutical Sciences, University of Alberta, Edmonton, Alberta T6G 2H1, Canada., Wuest M; Department of Oncology, University of Alberta, Edmonton, Alberta T6G 1Z2, Canada., Paiva IM; Faculty of Pharmacy and Pharmaceutical Sciences, University of Alberta, Edmonton, Alberta T6G 2H1, Canada., Leier S; Department of Oncology, University of Alberta, Edmonton, Alberta T6G 1Z2, Canada., Lavasanifar A; Faculty of Pharmacy and Pharmaceutical Sciences, University of Alberta, Edmonton, Alberta T6G 2H1, Canada., Wuest F; Faculty of Pharmacy and Pharmaceutical Sciences, University of Alberta, Edmonton, Alberta T6G 2H1, Canada.; Department of Oncology, University of Alberta, Edmonton, Alberta T6G 1Z2, Canada.
Publikováno v: Molecular pharmaceutics [Mol Pharm] 2024 Nov 04; Vol. 21 (11), pp. 5797-5806. Date of Electronic Publication: 2024 Oct 15.
Zobrazit plný text záznamu
2
Akademický článek
Targeting BCL2 with Venetoclax Enhances the Efficacy of the KRASG12D Inhibitor MRTX1133 in Pancreatic Cancer.
Autor: Becker JH; Department of Medicine, Feinberg School of Medicine, Northwestern University, Chicago, Illinois.; Jesse Brown VA Medical Center, Chicago, Illinois., Metropulos AE; Department of Medicine, Feinberg School of Medicine, Northwestern University, Chicago, Illinois.; Jesse Brown VA Medical Center, Chicago, Illinois., Spaulding C; Department of Medicine, Feinberg School of Medicine, Northwestern University, Chicago, Illinois.; Jesse Brown VA Medical Center, Chicago, Illinois., Marinelarena AM; Department of Medicine, Feinberg School of Medicine, Northwestern University, Chicago, Illinois., Shields MA; Department of Medicine, Feinberg School of Medicine, Northwestern University, Chicago, Illinois.; The Robert H. Lurie Comprehensive Cancer Center, Chicago, Illinois., Principe DR; Department of Medicine, Feinberg School of Medicine, Northwestern University, Chicago, Illinois., Pham TD; Department of Medicine, Feinberg School of Medicine, Northwestern University, Chicago, Illinois.; The Robert H. Lurie Comprehensive Cancer Center, Chicago, Illinois., Munshi HG; Department of Medicine, Feinberg School of Medicine, Northwestern University, Chicago, Illinois.; Jesse Brown VA Medical Center, Chicago, Illinois.; The Robert H. Lurie Comprehensive Cancer Center, Chicago, Illinois.
Publikováno v: Cancer research [Cancer Res] 2024 Nov 04; Vol. 84 (21), pp. 3629-3639.
Zobrazit plný text záznamu
4
Akademický článek
Bictegravir Use During Pregnancy: A Multicenter Retrospective Analysis Evaluating HIV Viral Suppression and Perinatal Outcomes.
Autor: Holt LM; Department of Gynecology and Obstetrics, Emory University School of Medicine, Atlanta, Georgia, USA., Short WR; Department of Internal Medicine, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania, USA., Momplaisir F; Department of Internal Medicine, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania, USA., Hyun E; University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania, USA., McKinney J; Department of Gynecology and Obstetrics, Baylor College of Medicine, Houston, Texas, USA., Lugo Morales A; Department of Gynecology and Obstetrics, Baylor College of Medicine, Houston, Texas, USA., Duque A; Baylor College of Medicine, Houston, Texas, USA., Druyan B; Department of Gynecology and Obstetrics, University of Miami School of Medicine, Miami, Florida, USA., Ndubizu C; Department of Gynecology and Obstetrics, University of Miami School of Medicine, Miami, Florida, USA., Duthely L; University of Miami School of Medicine, Miami, Florida, USA., Joseph N; Department of Obstetrics and Gynecology, Boston University School of Medicine, Boston, Massachusetts, USA., Sheth AN; Department of Internal Medicine, Emory University School of Medicine, Atlanta, Georgia, USA., Badell ML; Department of Gynecology and Obstetrics, Emory University School of Medicine, Atlanta, Georgia, USA.
Publikováno v: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America [Clin Infect Dis] 2024 Nov 22; Vol. 79 (5), pp. 1258-1261.
Zobrazit plný text záznamu
5
Akademický článek
Assessment of risk factors for virological nonsuppression following switch to dolutegravir and lamivudine, or bictegravir, emtricitabine, and tenofovir alafenamide fumarate in a real-world cohort of treatment-experienced adults living with HIV.
Autor: Lee SY; Department of Infectious Diseases, Taoyuan General Hospital, Ministry of Health and Welfare, Taoyuan City, Taiwan., Lin YC; Department of Infectious Diseases, Taoyuan General Hospital, Ministry of Health and Welfare, Taoyuan City, Taiwan., Chen CP; Department of Infectious Diseases, Taoyuan General Hospital, Ministry of Health and Welfare, Taoyuan City, Taiwan.; School of Clinical Medicine, National Yang-Ming Chiao Tung University, Taipei City, Taiwan., Cheng SH; Department of Infectious Diseases, Taoyuan General Hospital, Ministry of Health and Welfare, Taoyuan City, Taiwan.; School of Public Health, Taipei Medical University, Taipei City, Taiwan., Chang SY; Department of Nursing, Taoyuan General Hospital, Ministry of Health and Welfare, Taoyuan City, Taiwan., Ku SY; Department of Nursing, Taoyuan General Hospital, Ministry of Health and Welfare, Taoyuan City, Taiwan., Cheng CY; Department of Infectious Diseases, Taoyuan General Hospital, Ministry of Health and Welfare, Taoyuan City, Taiwan.; Institute of Public Health, School of Medicine, National Yang-Ming Chiao Tung University, Taipei City, Taiwan.
Publikováno v: PloS one [PLoS One] 2024 Nov 20; Vol. 19 (11), pp. e0314003. Date of Electronic Publication: 2024 Nov 20 (Print Publication: 2024).
Zobrazit plný text záznamu
6
Akademický článek
Bictegravir alters glucose tolerance in vivo and causes hepatic mitochondrial dysfunction.
Autor: García-Martínez P; Departamento de Farmacología, Universitat de València, Valencia, Spain; Fundación para El Fomento de La Investigación Sanitaria y Biomédica en La Comunidad Valenciana (FISABIO)-Hospital Universitario Doctor Peset, Valencia, Spain. Electronic address: patricia.garcia-martinez@uv.es., Gisbert-Ferrándiz L; Departamento de Farmacología, Universitat de València, Valencia, Spain; Fundación para El Fomento de La Investigación Sanitaria y Biomédica en La Comunidad Valenciana (FISABIO)-Hospital Universitario Doctor Peset, Valencia, Spain. Electronic address: laura.gisbert@uv.es., Álvarez Á; Departamento de Farmacología, Universitat de València, Valencia, Spain; Fundación para El Fomento de La Investigación Sanitaria y Biomédica en La Comunidad Valenciana (FISABIO)-Hospital Universitario Doctor Peset, Valencia, Spain; Centro de Investigación Biomédica en Red en Enfermedades Hepáticas y Digestivas (CIBERehd), Spain. Electronic address: angeles.alvarez@uv.es., Esplugues JV; Departamento de Farmacología, Universitat de València, Valencia, Spain; Fundación para El Fomento de La Investigación Sanitaria y Biomédica en La Comunidad Valenciana (FISABIO)-Hospital Universitario Doctor Peset, Valencia, Spain; Centro de Investigación Biomédica en Red en Enfermedades Hepáticas y Digestivas (CIBERehd), Spain. Electronic address: juan.v.esplugues@uv.es., Blas-García A; Fundación para El Fomento de La Investigación Sanitaria y Biomédica en La Comunidad Valenciana (FISABIO)-Hospital Universitario Doctor Peset, Valencia, Spain; Centro de Investigación Biomédica en Red en Enfermedades Hepáticas y Digestivas (CIBERehd), Spain; Departamento de Fisiología, Universitat de València, Valencia, Spain. Electronic address: ana.blas@uv.es.
Publikováno v: Antiviral research [Antiviral Res] 2024 Nov; Vol. 231, pp. 106020. Date of Electronic Publication: 2024 Oct 15.
Zobrazit plný text záznamu
7
Akademický článek
High efficacy of bictegravir/emtricitabine/tenofovir alafenamide (B/F/TAF) in Black adults in the United States, including those with pre-existing HIV resistance and suboptimal adherence.
Autor: Andreatta K; Gilead Sciences, Inc., Foster City, California, USA., D'Antoni ML; Gilead Sciences, Inc., Foster City, California, USA., Chang S; Gilead Sciences, Inc., Foster City, California, USA., Parvangada A; Gilead Sciences, Inc., Foster City, California, USA., Martin R; Gilead Sciences, Inc., Foster City, California, USA., Blair C; Gilead Sciences, Inc., Foster City, California, USA., Hagins D; Chatham CARE Center, Savannah, Georgia, USA., Kumar P; Georgetown University, Washington, DC, USA., Hindman JT; Gilead Sciences, Inc., Foster City, California, USA., Martin H; Gilead Sciences, Inc., Foster City, California, USA., Callebaut C; Gilead Sciences, Inc., Foster City, California, USA.
Publikováno v: Journal of medical virology [J Med Virol] 2024 Oct; Vol. 96 (10), pp. e29899.
Zobrazit plný text záznamu
8
Akademický článek
Safety and Efficacy of the Combination Lurbinectedin plus Doxorubicin from a Phase 1b Trial in Patients with Advanced/Metastatic Soft-Tissue Sarcoma.
Autor: Cote GM; Center for Sarcoma and Connective Tissue Oncology, Mass General Cancer Center, Boston, Massachusetts.; Harvard Medical School, Boston, Massachusetts., Haddox CL; Harvard Medical School, Boston, Massachusetts.; Sarcoma Division, Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts., Choy E; Center for Sarcoma and Connective Tissue Oncology, Mass General Cancer Center, Boston, Massachusetts.; Harvard Medical School, Boston, Massachusetts., Merriam PA; Harvard Medical School, Boston, Massachusetts., Mazzola E; Department of Data Science, Dana-Farber Cancer Institute, Boston, Massachusetts., Venkataraman V; Harvard Medical School, Boston, Massachusetts.; Sarcoma Division, Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts., Alcindor T; Harvard Medical School, Boston, Massachusetts.; Sarcoma Division, Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts., Wagner AJ; Harvard Medical School, Boston, Massachusetts.; Sarcoma Division, Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts., Demetri GD; Harvard Medical School, Boston, Massachusetts.; Sarcoma Division, Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Ludwig Center at Harvard, Boston, Massachusetts.; Dr. Miriam and Sheldon G. Adelson Medical Research Foundation, Boston, Massachusetts., George S; Harvard Medical School, Boston, Massachusetts.; Sarcoma Division, Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.
Publikováno v: Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2024 Jul 01; Vol. 30 (13), pp. 2702-2708.
Zobrazit plný text záznamu
9
Akademický článek
Simultaneous quantification of five antiretrovirals in human tissues using ultra-high performance liquid chromatography-tandem mass spectrometry methods for therapeutic drug monitoring at the sites of action.
Autor: West RE 3rd; Center for Clinical Pharmaceutical Sciences, Department of Pharmacy & Therapeutics, School of Pharmacy, University of Pittsburgh, Pittsburgh, PA, USA., Oberly PJ; Center for Clinical Pharmaceutical Sciences, Department of Pharmacy & Therapeutics, School of Pharmacy, University of Pittsburgh, Pittsburgh, PA, USA., Saylor AJ; Department of Medicine, School of Medicine, University of Pittsburgh, Pittsburgh, PA, USA., Riddler SA; Department of Medicine, School of Medicine, University of Pittsburgh, Pittsburgh, PA, USA., Nolin TD; Center for Clinical Pharmaceutical Sciences, Department of Pharmacy & Therapeutics, School of Pharmacy, University of Pittsburgh, Pittsburgh, PA, USA., Devanathan AS; Center for Clinical Pharmaceutical Sciences, Department of Pharmacy & Therapeutics, School of Pharmacy, University of Pittsburgh, Pittsburgh, PA, USA. Electronic address: asd129@pitt.edu.
Publikováno v: Journal of chromatography. B, Analytical technologies in the biomedical and life sciences [J Chromatogr B Analyt Technol Biomed Life Sci] 2024 Jul 01; Vol. 1241, pp. 124164. Date of Electronic Publication: 2024 May 25.
Zobrazit plný text záznamu
10
Akademický článek
[Translated article] Real-world persistence with dolutegravir/lamivudine versus bictegravir/emtricitabine/tenofovir-alafenamide among persons with HIV.
Autor: Martín-Zaragoza L; Servicio de Farmacia, Hospital Universitario de Getafe, Getafe, Spain. Electronic address: lmartinz@salud.madrid.org., Sánchez-Rubio-Ferrández J; Servicio de Farmacia, Hospital Universitario de Getafe, Getafe, Spain., Onteniente-González A; Servicio de Farmacia, Hospital Universitario de Getafe, Getafe, Spain., Gómez-Bermejo M; Servicio de Farmacia, Hospital Universitario de Getafe, Getafe, Spain., Rodríguez-Álvarez SJ; Servicio de Medicina Interna, Hospital Universitario de Getafe, Getafe, Spain., Monereo-Alonso A; Servicio de Medicina Interna, Hospital Universitario de Getafe, Getafe, Spain., Molina-García T; Servicio de Farmacia, Hospital Universitario de Getafe, Getafe, Spain.
Publikováno v: Farmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria [Farm Hosp] 2024 Jul-Aug; Vol. 48 (4), pp. T171-T175. Date of Electronic Publication: 2024 May 27.
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje